Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455179 | PMC |
| http://dx.doi.org/10.1055/a-1585-9536 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment.
Transfus Med Hemother
October 2024
Department of Hematology, Oncology, Elblandklinikum, Riesa, University Hospital, Dresden, Germany.
Article Synopsis
- Paroxysmal nocturnal hemoglobinuria (PNH) causes intravascular hemolysis due to a lack of complement regulation, leading to symptoms like anemia, pain, and fatigue, but can be treated with complement inhibitors to reduce disease-related complications and mortality.
- Eculizumab and ravulizumab, terminal complement inhibitors, improve survival rates, but many patients still experience issues from extravascular hemolysis, necessitating new treatment options.
- Proximal complement inhibitors (like pegcetacoplan, danicopan, and iptacopan) can help normalize hemoglobin levels and enhance quality of life for patients with significant extravascular hemolysis, though a clear treatment algorithm for choosing among
Intermittend pneumatic venous thrombembolism (VTE) prophylaxis during neurosurgical procedures.
Acta Neurochir (Wien)
June 2024
Department of Neurosurgery and Neurotechnology, Eberhard Karls University, Hoppe-Seyler-Straße 3, 72076, Tuebingen, Germany.
Background: The management of perioperative venous thrombembolism (VTE) prophylaxis is highly variable between neurosurgical departments and general guidelines are missing. The main issue in debate are the dose and initiation time of pharmacologic VTE prevention to balance the risk of VTE-based morbidity and potentially life-threatening bleeding. Mechanical VTE prophylaxis with intermittend pneumatic compression (IPC), however, is established in only a few neurosurgical hospitals, and its efficacy has not yet been demonstrated.
View Article and Find Full Text PDF[Secondary prophylaxis of ischemic stroke].
Inn Med (Heidelb)
December 2023
Klinik und Poliklinik für Neurologie, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, München, Deutschland.
The secondary prophylaxis of ischemic stroke provides an enormous therapeutic potential due to the high frequency of recurrent thrombembolic events and the exceptional importance of modifiable cardiovascular risk factors for the individual risk of stroke. In this respect, anti-thrombotic, interventional and surgical treatment options must be selected based on the respective etiology. Furthermore, meticulous optimization of risk factors is essential for effective long-term care.
View Article and Find Full Text PDFEditorial: Insights in thrombosis: 2022.
Front Cardiovasc Med
July 2023
Section of Internal Medicine and Thromboembolic Diseases, Department of Medicine and Geriatrics, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Ischemic Colitis in a Patient with Severe COVID-19 Pneumonia.
Case Rep Gastroenterol
August 2022
Department of Clinical Imaging, St. Anne's University Hospital, Masaryk University Faculty of Medicine, Brno, Czechia.
At the time of the current COVID-19 pandemic, on a daily basis, we encountered patients suffering from various manifestations of this infection. The most common are respiratory symptoms. Many of the patients require acute hospital care, and a smaller group of them are hospitalized in intensive care units.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!